Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes.
Jin R, Peng L, Shou J, Wang J, Jin Y, Liang F, Zhao J, Wu M, Li Q, Zhang B, Wu X, Lan F, Xia L, Yan J, Shao Y, Stebbing J, Shen H, Li W, Xia Y. Jin R, et al. Among authors: liang f. Front Oncol. 2021 Jun 14;11:680804. doi: 10.3389/fonc.2021.680804. eCollection 2021. Front Oncol. 2021. PMID: 34195081 Free PMC article.
Risk of COVID-19 in Patients With Cancer.
Peng L, Liang F, Xia Y. Peng L, et al. Among authors: liang f. JAMA Oncol. 2020 Sep 1;6(9):1469-1470. doi: 10.1001/jamaoncol.2020.2577. JAMA Oncol. 2020. PMID: 32614403 No abstract available.
Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002).
Shang X, Zhang W, Zhao G, Liang F, Zhang C, Yue J, Duan X, Ma Z, Chen C, Pang Q, Zhang W, Liu L, Ren X, Meng B, Zhang P, Ma Y, Zhang L, Li H, Kang X, Li Y, Jiang H. Shang X, et al. Among authors: liang f. Front Oncol. 2022 Mar 31;12:831345. doi: 10.3389/fonc.2022.831345. eCollection 2022. Front Oncol. 2022. PMID: 35433421 Free PMC article.
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001).
Shang X, Zhao G, Liang F, Zhang C, Zhang W, Liu L, Li R, Duan X, Ma Z, Yue J, Chen C, Meng B, Ren X, Jiang H. Shang X, et al. Among authors: liang f. Ann Transl Med. 2022 Feb;10(4):229. doi: 10.21037/atm-22-513. Ann Transl Med. 2022. PMID: 35280363 Free PMC article.
3,762 results